Product Details
Lioresal Intrathecal
Baclofen2 mg/mL
Solution for Injection
5-mL Pack (Preservative-Free)
DIN/PIN/NPN
02131064
Manufacturer
Novartis Pharma Canada Inc.
Formulary Listing Date
2015-08-26
Unit Price
NA
Amount MOH Pays
NA
Coverage Status
Off-Formulary Interchangeable Exceptional Access Program Product
ODB Formulary Therapeutic Classification
Therapeutic Note
Skeletal Muscle Relaxants (12:20:00): Muscle relaxants, other than baclofen and dantrolene sodium, are not indicated for spasticity due to cerebral palsy, multiple sclerosis, spinal cord injury, etc.
ATC Code
M03BX01
Interchangeable Products
| DIN/ PIN/ NPN | Brand name | Unit Price | Amount MOH pays |
|---|---|---|---|
| 02131064 | Lioresal Intrathecal | NA | NA |
| 02413647 | Baclofen Intrathecal | 35.4500 | 35.4500 |
| 02485516 | Baclofen Intrathecal | 35.4500 | 35.4500 |
| 02457075 | Baclofen Injection | 35.4500 | 35.4500 |
LU Clinical Criteria
NOEAP Criteria
| Therapeutic Class | Reimbursement Criteria |
|---|---|
| Unclassified EAP Drugs | These drugs are not currently listed in the Exceptional Access Program Reimbursement Criteria for Frequently Requested Drugs – August 8, 2023 Edition Physicians may wish to contact the EAP directly by phone at 416-327-8109 or 1-866-811-9893 or by email at EAPFeedback.MOH@ontario.ca to see if an unlisted drug product and/or indication may be considered for EAP funding. |